Income Taxes (Details) $ in Millions |
12 Months Ended |
---|---|
Dec. 31, 2021
USD ($)
| |
Stock-based compensation | $ 3.1 |
Patent impairment provision | 0.3 |
Net operating loss carry-forward | 11.7 |
Research and development tax credits | 0.3 |
Less: valuation allowance | (15.4) |
Total | 0.0 |
Net operating loss carry-forward | (11.7) |
Previously Reported [Member] | |
Stock-based compensation | 3.1 |
Patent impairment provision | 0.3 |
Net operating loss carry-forward | 27.6 |
Research and development tax credits | 0.3 |
Less: valuation allowance | (31.3) |
Total | 0.0 |
Net operating loss carry-forward | (27.6) |
Adjustment [Member] | |
Stock-based compensation | 0.0 |
Patent impairment provision | 0.0 |
Net operating loss carry-forward | 15.9 |
Research and development tax credits | 0.0 |
Total | 0.0 |
Net operating loss carry-forward | (15.9) |
Less: valuation allowance | $ 15.9 |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of noncash expense for share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|